Are you participating in one of our studies? Learn more about the benefits for you and your family.
From infants and their parents, to preschoolers, mid-late childhood youth, adolescents, young adults, and older adults, there are almost 9,000 families, youth, and spouse/significant others who have, or are, participating in LEAD Center studies. Learn more about the benefits of, and reasons for, participating in our research.
To all our participants and their families—thank you so very much for your continued support!
Learn more about a condition you have.
Gain knowledge and skills to lead a healthier lifestyle.
Help the next generation and advance science.
Learn more about our current research projects and how you can get involved.
The Healthy Start Study examines the metabolic and behavioral factors during pregnancy and early life that contribute to the development of obesity and related health problems.
Want more information? Check out the Healthy Start website.
Get in touch
Any comments, compliments or concerns you’d like to share? We would love to talk to you!
Phone: 303.724.4871
Email: Healthy.Start@ucdenver.edu
Healthy Start Facebook page
"[The] reason I agreed to being part of the study is so that other children may be helped by what [is] learned through the studies that are done. Every child deserves a healthy start in life."
Healthy Start Mom
This is a national collaborative project to harmonize 84 separate cohort studies of mothers and children in the United States (including Healthy Start) to increase greatly the ability to detect environmental influences on childhood health outcomes.
Environmental factors that will be studied include chemical and metals exposures, air pollution, pregnancy habits (diet, activity, medications), feeding habits after birth (breast, bottle, sold food introduction), the built environment
(parks, traffic, safety), mental health issues and other social factors, among many others.
Participants in the on-going Healthy Start study will be asked if they wish to become part of the ECHO collaboration, allowing the chance to share
information with over 80 other such studies, to leverage the amount and quality of all data to find the next generation of answers.
Visit the ECHO website
The Diabetes Prevention Program was a landmark clinical prevention trial in 27 sites in the US. Due to success, it ended early in 2001 and showed that lifestyle changes (weight loss and great physical activity) could reduce
the risk of type 2 diabetes by 58%! The drug metformin also reduced risk by 31% over 3 years. The DPPOS (DPP Outcomes Study) is following the vast majority of DPP participants for up to 20 years, now for continued prevention of diabetes, as well as
complications of diabetes, and is asking the question of whether taking metformin lowers the risk of cancer.
The 10-year follow-up of the DPP shows that both lifestyle (solid purple line) and metformin (solid red line) continue to have
lower diabetes new cases than placebo (dashed blue line)!
"DPP and all it has to offer – education, events, health screenings, eye photos, etc. – mean the world to me. All my counselors have diabetes prevention program outcomes study logobeen great, and I consider them friends"
DPP participant
The SEARCH Study has two major parts: 1) the Registry, 2) the Cohort Study.
The Registry study connects with youth in five geographic areas, including the entire state of Colorado, as well as American Indian youth on reservations in Arizona and New Mexico; the entire state of South Carolina; counties
around and including Cincinnati, Ohio and Seattle Washington; and members of the Kaiser Permanente of Southern California Health Plan. The goal is to understand the burden of diabetes that occurs from birth to age 19 years.
The Cohort study
is following youth with both type 1 and type 2 diabetes from near the time they were diagnosed for up to 10 years, and still counting. Over 2,000 youth from the five registry sites (almost 600 in Colorado) are being followed to see if any diabetes
complications are occurring as they age. Important tests for eye disease (retinopathy), kidney disease (nephropathy), nerve system disease (neuropathy), and cardiovascular risk factors (blood lipids, blood pressure, heart rate variation, and blood
vessel stiffness) are performed.
The incidence (new cases) of both type 1 and type 2 diabetes has increased over the past 10 years - type 1 diabetes has had an average increase of 1.4%, and type 2 diabetes has had an average increase of 7.1%. (Incidence Trends of Type 1 and Type 2 Diabetes among Youths)
Along with incidence, prevalence (existing cases) has also increased. (Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009)
The study has been examining adolescents and young adults over time to learn what the burden of complications is by type 1 and type 2 diabetes. We have found that early complications of the eye, kidney, nerves, and arteries is already found after only eight years in some youth, and the burden is higher among those with type 2 diabetes than in type 1 youth, and is also higher in minority youth. (Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood)
This figure shows the main results – dark blue bars are type 2, light blue bars are type 1. The height of the bars is the percent of youth with the condition. “All’ is all race/ethnic groups combined, ‘NHW’ is non-Hispanic
white and ‘other’ is all other race/ethnic groups combined.
Visit the National SEARCH Website